Get started
Work

Supplementary Table S1 from Phase I Safety, Pharmacokinetic and Pharmacodynamic Evaluation of the Vascular Disrupting Agent Ombrabulin (AVE8062) in Patients with Advanced Solid Tumors

Year: 2023
Type: supplementary-materials
Abstract: Supplementary Table S1 - PDF file 52K, Best overall tumor response (RECIST)
DOI: 10.1158/1078-0432.22449270
Authors: Cristiana Sessa, Patricia Lorusso, Anthony Tolcher, Françoise Farace, Nathalie Lassau, Angelo Delmonte, Antonio Braghetti, Rastislav Bahleda, Patrick Cohen, Marie Hospitel, Christine Veyrat-Follet, Jean-Charles Soria
Language: English
Open Access status: gold
OpenAlex ID: W4361827556
Cites:
Cited by:
Related to: 10